2022-07-01 2023-06-30 false Capium Accounts Production 1.1 12048993 bus:AbridgedAccounts 2022-07-01 2023-06-30 12048993 bus:FRS102 2022-07-01 2023-06-30 12048993 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 12048993 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 12048993 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 12048993 2022-07-01 2023-06-30 12048993 2023-06-30 12048993 bus:RegisteredOffice 2022-07-01 2023-06-30 12048993 core:WithinOneYear 2023-06-30 12048993 core:AfterOneYear 2023-06-30 12048993 bus:Director1 2022-07-01 2023-06-30 12048993 bus:Director1 2023-06-30 12048993 bus:Director1 2021-07-01 2022-06-30 12048993 2021-07-01 12048993 bus:CompanySecretary1 2022-07-01 2023-06-30 12048993 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 12048993 2021-07-01 2022-06-30 12048993 2022-06-30 12048993 core:WithinOneYear 2022-06-30 12048993 core:AfterOneYear 2022-06-30 12048993 bus:EntityAccountantsOrAuditors 2021-07-01 2022-06-30 12048993 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 12048993 bus:OrdinaryShareClass1 2023-06-30 12048993 bus:OrdinaryShareClass1 2021-07-01 2022-06-30 12048993 bus:OrdinaryShareClass1 2022-06-30 12048993 core:FurnitureFittings 2022-07-01 2023-06-30 12048993 core:FurnitureFittings 2023-06-30 12048993 core:FurnitureFittings 2022-06-30 12048993 core:ComputerEquipment 2022-07-01 2023-06-30 12048993 core:ComputerEquipment 2023-06-30 12048993 core:ComputerEquipment 2022-06-30 12048993 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-06-30 12048993 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-06-30 12048993 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 12048993 core:CostValuation core:Non-currentFinancialInstruments 2022-06-30 12048993 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-06-30 12048993 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 12048993 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 12048993 core:Non-currentFinancialInstruments 2023-06-30 12048993 core:Non-currentFinancialInstruments 2022-06-30 12048993 core:ShareCapital 2023-06-30 12048993 core:ShareCapital 2022-06-30 12048993 core:RetainedEarningsAccumulatedLosses 2023-06-30 12048993 core:RetainedEarningsAccumulatedLosses 2022-06-30 12048993 dpl:Item1 2022-07-01 12048993 dpl:Item1 2023-06-30 12048993 dpl:Item1 2021-07-01 12048993 dpl:Item1 2022-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12048993
England and Wales

 

 

 

RESTORE MEDICAL LTD


Abridged Accounts
 


Period of accounts

Start date: 01 July 2022

End date: 30 June 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have compiled for your approval the financial statements of Restore Medical Ltd for the year ended 30 June 2023 which comprise the Profit and Loss Account, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

This report is made solely to the director of Restore Medical Ltd in accordance with our terms of engagement. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Restore Medical Ltd has kept adequate accounting records
and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Restore Medical Ltd.
You consider that Restore Medical Ltd is exempt from the statutory audit requirement for the period and we have not been instructed to carry out an audit or a review of the financial statements of Restore Medical Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.


Burton Varley Ltd
Suite 3, 2nd Floor, Didsbury House
748 - 754 Wilmslow Road
Manchester
M20 2DW
06 November 2023
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 4,779    1,712 
4,779    1,712 
Current assets      
Debtors 1,696    4,585 
Cash at bank and in hand 95,169    103,315 
96,865    107,900 
Creditors: amount falling due within one year (6,397)   (17,934)
Net current assets 90,468    89,966 
 
Total assets less current liabilities 95,247    91,678 
Net assets 95,247    91,678 
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 95,246    91,677 
Shareholder's funds 95,247    91,678 
 


For the year ended 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 06 November 2023 and were signed by:


-------------------------------
Sarah Tingling
Director
2
General Information
Restore Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 12048993, registration address C/O Burton Varley Ltd, Suite 3 2nd Floor, Didsbury House, 748 - 754 Wilmslow Road,, Manchester, M20 2DW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 20% Straight Line
Computer Equipment 25% Straight Line
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Computer Equipment   Total
  £   £   £
At 01 July 2022 307    2,600    2,907 
Additions 3,843      3,843 
Disposals    
At 30 June 2023 4,150    2,600    6,750 
Depreciation
At 01 July 2022 17    1,178    1,195 
Charge for year 109    667    776 
On disposals    
At 30 June 2023 126    1,845    1,971 
Net book values
Closing balance as at 30 June 2023 4,024    755    4,779 
Opening balance as at 01 July 2022 290    1,422    1,712 


4.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
1 Class A share of £1.00 each  
 

3